Research / OKTA / Fundamental state Inspectable configuration
State dimensions Filing 0001660134-20-000019 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.37% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
5.45% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
42.69% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
74.48% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-22.64% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
26.87% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
24.14% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Oct 31, 2021 7/7 normalized Level 3 Jan 31, 2022 7/7 normalized Level 3 Apr 30, 2022 7/7 normalized Level 3 Jul 31, 2022 7/7 normalized Level 3 Oct 31, 2022 7/7 normalized Level 3 Jan 31, 2023 7/7 normalized Level 3 Apr 30, 2023 7/7 normalized Level 3 Jul 31, 2023 7/7 normalized Level 3 Oct 31, 2023 7/7 normalized Level 3 Jan 31, 2024 7/7 normalized Level 3 Apr 30, 2024 7/7 normalized Level 3 Jul 31, 2024 7/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 4.34%
Current 1.37%
Delta -2.97% Cash Generation Decreased
Previous 21.16%
Current 5.45%
Delta -15.71% Growth Decreased
Previous 46.03%
Current 42.69%
Delta -3.34% Margin Increased
Previous 73.48%
Current 74.48%
Delta 1.00% Profitability Increased
Previous -28.55%
Current -22.64%
Delta 5.90% R And D Intensity Increased
Previous 26.52%
Current 26.87%
Delta 0.35% Sbc Intensity Increased
Previous 20.63%
Current 24.14%
Delta 3.51% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.